http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0240330-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22c3adadb5cc72c5069c682947605aac |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
| filingDate | 1989-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_157bed8dfd9aaa2a31cbebd011cd302a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ead1372ed249e971f797d35bcfd26001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2dab3af96ebaa6e089e1b1fe414173e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6aafcf134291293267cbaff9add0572 |
| publicationDate | 1990-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H0240330-A |
| titleOfInvention | Use of choline release acting agent and growth hormone-releasing hormone for preparing medicinal composition useful for differential diagnosis of somatotropin deficiency |
| abstract | PURPOSE: To obtain a composition containing a choline release acting agent and a growth hormone-releasing hormone(GHRH) and useful for a differential diagnosis of somatotropin deficiency. n CONSTITUTION: This medicinal composition is a diagnostic composition containing a choline release acting agent such as carbachol, arecoline, neostigmine and pyridostigmine with GHRH and can be used for performing a differential diagnosis whether a somatotropin deficiency is in a pituitary stage or in a hypothalamus stage. The composition is preferably prepared as in a form of an injection liquid used for an intravenous or an intramuscular injection, and the content of the choline release acting agent is in a range of 0.01-7.5wt.% and the content of GHRH is in a range of 0.001-0.75wt.% in the injection liquid. By the differential diagnosis with the composition, the most effective treatment (for the pituitary stage, a growth hormone is administered and for the hypothalamus stage, GHRH is administered) can be decided. n COPYRIGHT: (C)1990,JPO |
| priorityDate | 1988-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 144.